1. Home
  2. GBIO vs MODD Comparison

GBIO vs MODD Comparison

Compare GBIO & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • MODD
  • Stock Information
  • Founded
  • GBIO 2016
  • MODD 1998
  • Country
  • GBIO United States
  • MODD United States
  • Employees
  • GBIO N/A
  • MODD N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • MODD Industrial Specialties
  • Sector
  • GBIO Health Care
  • MODD Health Care
  • Exchange
  • GBIO Nasdaq
  • MODD Nasdaq
  • Market Cap
  • GBIO 41.2M
  • MODD 34.8M
  • IPO Year
  • GBIO 2020
  • MODD N/A
  • Fundamental
  • Price
  • GBIO $6.71
  • MODD $0.58
  • Analyst Decision
  • GBIO Buy
  • MODD
  • Analyst Count
  • GBIO 4
  • MODD 0
  • Target Price
  • GBIO $10.67
  • MODD N/A
  • AVG Volume (30 Days)
  • GBIO 39.3K
  • MODD 280.1K
  • Earning Date
  • GBIO 11-05-2025
  • MODD 11-13-2025
  • Dividend Yield
  • GBIO N/A
  • MODD N/A
  • EPS Growth
  • GBIO N/A
  • MODD N/A
  • EPS
  • GBIO N/A
  • MODD N/A
  • Revenue
  • GBIO $21,230,000.00
  • MODD N/A
  • Revenue This Year
  • GBIO N/A
  • MODD N/A
  • Revenue Next Year
  • GBIO N/A
  • MODD N/A
  • P/E Ratio
  • GBIO N/A
  • MODD N/A
  • Revenue Growth
  • GBIO 61.15
  • MODD N/A
  • 52 Week Low
  • GBIO $3.00
  • MODD $0.57
  • 52 Week High
  • GBIO $25.70
  • MODD $2.37
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 65.83
  • MODD 23.01
  • Support Level
  • GBIO $6.08
  • MODD $0.57
  • Resistance Level
  • GBIO $6.48
  • MODD $0.67
  • Average True Range (ATR)
  • GBIO 0.33
  • MODD 0.03
  • MACD
  • GBIO -0.01
  • MODD -0.01
  • Stochastic Oscillator
  • GBIO 83.58
  • MODD 6.29

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About MODD Modular Medical Inc.

Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.

Share on Social Networks: